These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 10188912

  • 1. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
    Majumdar S, Diamandis EP.
    Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
    Suzuki S, Tadakuma T, Asano T, Hayakawa M.
    Cancer Res; 2001 Feb 15; 61(4):1276-9. PubMed ID: 11245419
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
    Lai J, Myers SA, Lawrence MG, Odorico DM, Clements JA.
    Mol Cancer Res; 2009 Jan 15; 7(1):129-41. PubMed ID: 19147544
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
    Chapel-Fernandes S, Jordier F, Lauro F, Maitland N, Chiaroni J, de Micco P, Mannoni P, Bagnis C.
    Cancer Gene Ther; 2006 Oct 15; 13(10):919-29. PubMed ID: 16741521
    [Abstract] [Full Text] [Related]

  • 14. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J.
    Mol Endocrinol; 1997 Feb 15; 11(2):148-61. PubMed ID: 9013762
    [Abstract] [Full Text] [Related]

  • 15. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H, Levesque MA, Clark GM, Diamandis EP.
    Br J Cancer; 1999 Oct 15; 81(3):490-5. PubMed ID: 10507775
    [Abstract] [Full Text] [Related]

  • 16. NOEY2 mutations in primary breast cancers and breast hyperplasia.
    Yang J, Hu A, Wang L, Li B, Chen Y, Zhao W, Xu W, Li T.
    Breast; 2009 Jun 15; 18(3):197-203. PubMed ID: 19482475
    [Abstract] [Full Text] [Related]

  • 17. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
    Yu DC, Sakamoto GT, Henderson DR.
    Cancer Res; 1999 Apr 01; 59(7):1498-504. PubMed ID: 10197620
    [Abstract] [Full Text] [Related]

  • 18. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
    Downing S, Bumak C, Nixdorf S, Ow K, Russell P, Jackson P.
    Mol Carcinog; 2003 Nov 01; 38(3):130-40. PubMed ID: 14587098
    [Abstract] [Full Text] [Related]

  • 19. Novel polymorphisms in prostate specific antigen gene and its association with prostate cancer.
    Yang Q, Shan L, Segawa N, Nakamura M, Nakamura Y, Mori I, Sakurai T, Kakudo K.
    Anticancer Res; 2001 Nov 01; 21(1A):197-200. PubMed ID: 11299734
    [Abstract] [Full Text] [Related]

  • 20. [Constructing recombinant plasmid with prostate-specific membrane antigen promoter and reverse enhancer and comparing the transcription activity of enhancers in different directions].
    Zeng H, Liao YC, Wang F, Wu Q, Yang YR.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov 01; 36(6):782-5. PubMed ID: 16334552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.